The efficacy of Ursodeoxycholic on faster improvement of patients with psoriasis
Not Applicable
Recruiting
- Conditions
- Psoriasis.psoriasis vulgaris
- Registration Number
- IRCT2017092536415N1
- Lead Sponsor
- Tehran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
patients with psoriasis who are candidated for systemic therapy; they have not received systemic therapy as well as phtotherapy for their disease during the past 6 month; they have not received topical treatment over the past month.
Exclusion criteria: patients with history of heart failure, hepatic, renal and pulmonary disease or icreasement in liver function tests(More than 1.5 times normal), diabetes mellitus and other serious systemic disease; pregnant women; since the efficacy and safety of using Uroseodocyclic acid in the pediatric population has not been established, this group will also be excluded from the study; People with a history of biliary disorders, and hypersensitivity to bile acids
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method